SCHRODER INVESTMENT MANAGEMENT GROUP

Position in EYPT — EyePoint, Inc.

CIK 1086619 London, X0

Position in EYPT

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$2,817,109

-$259,230 QoQ

Shares Held

218,550

+29.8% QoQ

Ownership

0.261%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SCHRODER INVESTMENT MANAGEMENT GROUP holds $603,082,920 across 77 Biotechnology names. EYPT ranks #49 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	163,898	$73,187,011
2	TECH	BIO-TECHNE Corp	1,197,214	$62,566,403
3	EXEL	Exelixis, Inc.	525,533	$22,540,109
4	ALNY	Alnylam Pharmaceuticals, Inc.	66,662	$22,056,454
5	SLNO	Soleno Therapeutics Inc	648,827	$21,722,727
6	MDGL	Madrigal Pharmaceuticals, Inc.	39,852	$20,861,326
7	INSM	INSMED Inc	119,958	$19,615,531
8	VERA	Vera Therapeutics, Inc.	484,381	$19,486,647

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,817,109	218,550	+29.8%	Shares	Sole	2026-05-14
2025-12-31	$3,076,339	168,382	-32.0%	Shares	Sole	2026-02-13
2025-09-30	$3,528,016	247,754	-21.1%	Shares	Sole	2025-11-13
2025-06-30	$2,954,542	313,979	+21.7%	Shares	Sole	2025-08-13
2025-03-31	$1,398,278	257,985	-4.6%	Shares	Sole	2025-05-13
2024-12-31	$2,014,003	270,336	+118.1%	Shares	Sole	2025-02-12
2024-09-30	$990,224	123,933	-1.0%	Shares	Sole	2024-11-13
2024-06-30	$1,088,561	125,122	-59.1%	Shares	Sole	2024-08-12
2024-03-31	$6,329,278	306,206	+70.1%	Shares	Sole	2024-05-14
2023-12-31	$4,159,800	180,000	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.